المؤلفون: Lazaratos AM; Rosalind and Morris Goodman Cancer Institute, Montreal, Quebec, Canada; Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada., Maritan SM; Rosalind and Morris Goodman Cancer Institute, Montreal, Quebec, Canada; Faculty of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada., Quaiattini A; Schulich Library of Physical Sciences, Life Sciences, and Engineering, McGill University, Montreal, Quebec, Canada., Darlix A; Department of Medical Oncology, Institut régional du Cancer de Montpellier, University of Montpellier, Montpellier, France; Institut de Génomique Fonctionnelle, INSERM, CNRS, University of Montpellier, Montpellier, France., Ratosa I; Division of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Ferraro E; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NewYork, USA., Griguolo G; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy., Guarneri V; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy., Pellerino A; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy., Hofer S; Department of Neurology, University Hospital Zurich, Switzerland., Jacot W; Department of Medical Oncology, Institut régional du Cancer de Montpellier, University of Montpellier, Montpellier, France., Stemmler HJ; Medical Dept. III, Ludwig Maximilians University Munich, Munchen, Germany., van den Broek MPH; Clinical Pharmacy, Sint Antonius Hospital, Nieuwegein, the Netherlands., Dobnikar N; Division of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Panet F; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada., Lahijanian Z; Department of Diagnostic Radiology, McGill University, Montreal, Quebec, Canada., Morikawa A; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NewYork, USA., Seidman AD; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NewYork, USA., Soffietti R; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy., Panasci L; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada., Petrecca K; Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada., Rose AAN; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada; Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada., Bouganim N; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada; McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Dankner M; Rosalind and Morris Goodman Cancer Institute, Montreal, Quebec, Canada; Faculty of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada. Electronic address: matthew.dankner@mail.mcgill.ca.

المصدر: Breast (Edinburgh, Scotland) [Breast] 2023 Jun; Vol. 69, pp. 451-468. Date of Electronic Publication: 2023 May 01.

نوع المنشور: Journal Article; Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Receptor, ErbB-2*/antagonists & inhibitors , Trastuzumab*/administration & dosage , Trastuzumab*/therapeutic use , Meningeal Neoplasms*/secondary, Female ; Humans ; Ado-Trastuzumab Emtansine/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols ; Prospective Studies ; Randomized Controlled Trials as Topic

المؤلفون: Swartz, Leigh Klaus^Aff5, Morikawa, Aki^Aff5

المساهمون: Ramakrishna, Rohan, editor^Aff1, Magge, Rajiv S., editor^Aff2, Baaj, Ali A., editor^Aff3, Knisely, Jonathan P.S., editor^Aff4

المصدر: Central Nervous System Metastases : Diagnosis and Treatment. :219-233